Sound Pharmaceuticals concludes subject enrolment for SPI-1005 trial
Sound Pharmaceuticals has concluded subject enrolment for its second Phase III clinical trial assessing SPI-1005 in adults with probable or…
News
Neuraptive secures exclusive licence from Washington University for nerve device
Innovent licenses IBI355 rights to Spero for up to $1.1bn
Claria Medical secures FDA De Novo classification for hysterectomy device
First participant dosed in Ionis’ Phase I-II ASCEND study
Cellares and Sonoma partner to automate cell therapy manufacturing
Virax Biolabs enters immune profiling product supply deal with Fosun
Novo Nordisk reports Phase III FRONTIER4 study results for denecimig
